Drug
Lesogaberan clinical trials
Also written AZD3355.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
10 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses lesogaberan is read from its arms, and is right about nine times in ten.
Testing it · 10
- Lesogaberan in Chinese Patients With Refractory Reflux SymptomsStatus unknownPhase 2National Taiwan University HospitalNCT02818309Written as Lesogaberan
- TLESR-impedance Study in PatientsCompletedPhase 2AstraZenecaNCT00743444Written as AZD3355
- Symptom Improvements in Gastroesophageal Reflux Disease (GERD) PatientsCompletedPhase 2AstraZenecaNCT00394472Written as AZD3355
- Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) SymptomsCompletedPhase 2AstraZenecaNCT00703534Written as AZD3355
- A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May ExperienceCompletedPhase 2AstraZenecaNCT01043185Written as AZD3355
- Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPICompletedPhase 2AstraZenecaNCT01005251Written as lesogaberan (AZD3355)
- Renal Impairment StudyCompletedPhase 1AstraZenecaNCT00863161Written as AZD3355
- AZD3355 Dose-escalation Study in Healthy MalesCompletedPhase 1AstraZenecaNCT00757419Written as AZD3355
- Drug Interaction Study Between AZD3355 and NexiumCompletedPhase 1AstraZenecaNCT00684190Written as AZD3355
- Study to Compare Different Formulations of AZD3355CompletedPhase 1AstraZenecaNCT00688402Written as AZD3355
Codes
What other systems call lesogaberan · ClinicalTrials.gg INT005516
- MeSH (NLM) C545087lesogaberanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 4D6Q6HGC7ZLESOBAGERANConfirmed FDA, NLM, Wikidata
- Wikidata Q4864584lesogaberanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166751LesogaberanOne source FDA
- DrugBank DB11920One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C545087 | lesogaberan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 4D6Q6HGC7Z | LESOBAGERAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4864584 | lesogaberan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166751 | Lesogaberan | One source FDA |
| DrugBank | DB11920 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.